Dose Response Curve
The dose response curve is a graphical representation of the relationship between the amount of a stimulus (such as a drug or hormone) and its effects. The shape of the curve can vary depending on the type of substance.
Stimulus Types
There are three types of stimuli that underpin the fundamental functions of drugs on the human body.
Allosteric modulators, also known as allosteric effectors, are substances that bind to an enzyme or receptor at one site and change their activity at another site. Allosteric modulators typically cause an increase in response up to a certain point before plateauing off. This produces an “S” shaped dose-response curve.
Antagonists are substances which bind to receptors but do not activate them, thus blocking any other agonists from activating it too. Antagonists produce bell-shaped curves when graphed out with different doses producing different levels of inhibition until eventually no more inhibition occurs past a certain point.
Agonists are molecules that bind to receptors and stimulate them into action; they usually produce linear dose response curves since higher doses lead to increased stimulation although there may be saturation points past which further increases in concentration have no further effect on activation levels.
For Antagonists, the mathematical formula used to calculate dose response curves is called the Hill equation. It describes how changes in drug concentration can affect receptor occupancy and binding affinity. The Hill equation is expressed as:
R = Bmax*[C]n/(Kd^n + [C]^n)
See
Where R is receptor occupancy (or efficacy), Bmaxis maximum possible receptor occupancy, C is ligand concentration, Kdis dissociation constant of the ligand-receptor complex, and n is a cooperativity coefficient that indicates how tightly bound each ligand molecule needs to be before it binds to its partner on the surface of a cell.
For Agonists, two different types of mathematical formulas are used for calculating dose response curves: sigmoidal equations and direct agonist models. Sigmoidal equations such as the Emax model or four-parameter logistic function describe how an agonist’s activity increases nonlinearly with increasing concentrations up to a certain point before plateauing off at higher concentrations. Direct agonist models such as Schild analysis use linear regression methods to fit receptors’ responses directly to various concentrations of an agonist without any curve fitting techniques.
Finally, Allosteric modulators are typically modeled using cooperative binding equations which consider both activators and inhibitors simultaneously. These equations include both hyperbolic equations like Michaelis-Menten kinetics or Langmuir adsorption models for reversible reactions, as well as allosteric modulation functions which take into account factors such as allostery type (positive/negative), cooperativity coefficients (α & β), effectors’ affinities (Ka & Ki) etc., allowing them to accurately predict effects of allosteric modulators on cellular pathways over time.
Antagonists
Naloxone: Naloxone is a medication used to reverse the effects of opioid medications and drugs. It works by blocking opioid receptors in the brain, preventing opioids from binding to them and producing their effects such as pain relief, sedation, and euphoria.
Buprenorphine: Buprenorphine is an opioid partial agonist-antagonist that binds to the same receptors as other opioids but only partially activates them, thus limiting its potential for abuse or misuse. It also blocks other opioids from attaching to these certain receptors making it difficult for individuals who are addicted to opioids to get high on heroin or prescription painkillers when taking buprenorphine instead.
Flumazenil: Flumazenil is a benzodiazepine antagonist that blocks benzodiazepines from attaching onto their appropriate receptor sites in the brain and prevents them from exerting any effect on an individual’s nervous system or behavior. This helps reverse sedative effects caused by benzodiazepines such as anxiolysis, muscle relaxation, amnesia and respiratory depression among others
Agonists
A. Epinephrine: Epinephrine is a sympathomimetic agonist drug, meaning it mimics the action of the hormone adrenaline released by our body during times of stress or danger. It activates alpha-adrenergic receptors located on smooth muscles to cause contraction, as well as beta-adrenergic receptors which stimulate heart rate and force of contractions, and dopamine receptor sites which can increase alertness levels in some cases. In addition, epinephrine increases blood flow to skeletal muscle tissue by dilating vessels and increasing cardiac output via its effect on both alpha-and beta-receptors on vascular walls.
B. Isoproterenol: Isoproterenol is another sympathomimetic agonist drug with similar effects to epinephrine but more pronounced effects on cardiac function due to stronger activation of beta-receptors rather than alpha-receptor sites for vasoconstriction like epinephrine does . This means that isoproterenol causes greater increases in heart rate and force of contraction than epinephrine; however it results in less peripheral vascular resistance (blood pressure) response compared to epinpehrine since there’s no concurrent activation of alpha receptors for vasoconstriction with this drug alone as there was with epi/norepi combo used clinically before more specific drugs were available for use such as norepinepherines selective agonists dobutamine or milrinone today instead now days because those two agents target just one type each either only Beta (dobutamine) or just Alpha (milronone).
C. Salbutamol: Salbutamol is a bronchodilator agent belonging to the family known as β2 adrenoceptor agonists that act primarily within airways by stimulating β2 adrenoceptors found predominantly near smooth muscle tissues lining bronchi and bronchioles allowing them relax so they can open up wider improving airflow into lungs thus relieving symptoms associated with asthma attack or other respiratory conditions caused by constricted airways such like COPD (Chronic obstructive pulmonary disease).
Allosteric Modulators
Fostamatinib (R788): Fostamatinib is an allosteric modulator that works by binding to and inhibiting the activity of Syk kinase, a protein involved in many signaling pathways that are altered in autoimmune diseases such as rheumatoid arthritis. By blocking Syk, fostamatinib prevents inflammatory responses from occurring and helps reduce the symptoms associated with these disorders.
Galantamine: Galantamine is a drug used to treat Alzheimer’s disease by acting as an allosteric modulator of nicotinic acetylcholine receptors (nAChRs). It binds to sites on the nAChR which results in increased sensitivity of the receptor and enhanced cholinergic transmission within the brain. This improved cholinergic transmission can help improve memory formation, recall, and overall cognitive function for those suffering from Alzheimer’s disease.
Flumazenil: Flumazenil is an allosteric modulator that works by binding to benzodiazepine receptors in the central nervous system (CNS) and reversing their effects caused by benzodiazepines such as drowsiness or sedation. By binding to these sites, flumazenil blocks any further activity of benzodiazipines on those receptors thus allowing normal CNS functioning to return quickly without side-effects or withdrawal symptoms commonly seen when abrupt discontinuation occurs with other drugs like alcohol or opioids.